Histological mapping of biochemical changes in solid tumors by FT‐IR spectral imaging
暂无分享,去创建一个
Cyril Petibois | Andreas Bikfalvi | Gérard Déléris | A. Bikfalvi | G. Déléris | B. Drogat | C. Petibois | Michel Moenner | Benjamin Drogat | M. Moenner | G. Deleris | Benjamin Drogat
[1] S. Hewitt,et al. Infrared spectroscopic imaging for histopathologic recognition , 2005, Nature Biotechnology.
[2] I. W. Levin,et al. Fourier transform infrared vibrational spectroscopic imaging: integrating microscopy and molecular recognition. , 2005, Annual review of physical chemistry.
[3] J. Pouysségur,et al. Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.
[4] Aftab Ahmad,et al. Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[5] M. Dewhirst,et al. Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. , 2005, Cancer research.
[6] Andreas Bikfalvi,et al. Accessing key steps of human tumor progression in vivo by using an avian embryo model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[7] Cyril Petibois,et al. Oxidative stress effects on erythrocytes determined by FT-IR spectrometry. , 2004, The Analyst.
[8] E. Chevet,et al. Acute L‐glutamine deprivation compromises VEGF‐a upregulation in A549/8 human carcinoma cells , 2007, Journal of cellular physiology.
[9] G. Déléris,et al. Evidence that erythrocytes are highly susceptible to exercise oxidative stress: FT‐IR spectrometric studies at the molecular level , 2005, Cell biology international.
[10] Cyril Petibois,et al. Analytical performances of FT-IR spectrometry and imaging for concentration measurements within biological fluids, cells, and tissues. , 2006, The Analyst.
[11] Cyril Petibois,et al. Chemical mapping of tumor progression by FT-IR imaging: towards molecular histopathology. , 2006, Trends in biotechnology.
[12] Jinsong Liu,et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.
[13] David I. Ellis,et al. Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. , 2006, The Analyst.
[14] M. Guppy,et al. The hypoxic core: a possible answer to the cancer paradox. , 2002, Biochemical and biophysical research communications.
[15] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.